{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:14:57Z","timestamp":1777900497412,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017804","name":"City of Hope","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.gore.2025.101989","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:11:18Z","timestamp":1762783878000},"page":"101989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Somatically derived ovarian yolk sac tumor in a postmenopausal woman: A case report of durable remission with personalized chemotherapy"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-842X","authenticated-orcid":false,"given":"Vinita","family":"Popat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Rucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Rodriguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.gore.2025.101989_b0005","first-page":"36","article-title":"Outcome of treatment with EMA\/EP (etoposide methotrexate and actinomycin-D\/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia","volume":"3","author":"Aminimoghaddam","year":"2018","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"44","key":"10.1016\/j.gore.2025.101989_b0010","article-title":"Somatic yolk sac differentiation in tumors of the gynecologic tract: a report of two cases and review of the literature","volume":"13","author":"Bassi","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.gore.2025.101989_b0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/10668969211030688","article-title":"Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma","volume":"30","author":"Collins","year":"2022","journal-title":"Int. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.gore.2025.101989_b0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2016.07.005","article-title":"Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors","volume":"142","author":"De la Motte","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101989_b0025","unstructured":"de La Motte, R.T., Pautier, P., Rey, A., et al. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases."},{"issue":"27","key":"10.1016\/j.gore.2025.101989_b0030","first-page":"22","article-title":"Successful yolk-sac tumor treatment with fertility-sparing partial oophorectomy","volume":"30","author":"Dunn","year":"2018","journal-title":"Gynecol. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.gore.2025.101989_b0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/annonc\/mdt369","article-title":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)","volume":"25","author":"Grimison","year":"2014","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2025.101989_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PAS.0000000000001777","article-title":"Vulvar Yolk Sac Tumors are Somatically Derived SMARCB1 (INI-1)-Deficient Neoplasms","volume":"46","author":"Kolin","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.gore.2025.101989_b0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/his.13021","article-title":"Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours","volume":"69","author":"McNamee","year":"2016","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.gore.2025.101989_b0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/his.13973","article-title":"Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases","volume":"76","author":"Murakami","year":"2020","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.gore.2025.101989_b0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ygyno.2017.08.013","article-title":"Management, and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base","volume":"147","author":"Nasioudis","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.gore.2025.101989_b0060","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S1470-2045(20)30091-7","article-title":"ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers","volume":"21","author":"Sessa","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.gore.2025.101989_b0065","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41379-020-0548-6","article-title":"Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation","volume":"33","author":"Skala","year":"2020","journal-title":"Modern Pathol."},{"issue":"3","key":"10.1016\/j.gore.2025.101989_b0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/08880018809031272","article-title":"Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma","volume":"5","author":"Walhof","year":"1988","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"33","key":"10.1016\/j.gore.2025.101989_b0075","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011838","article-title":"Ovarian yolk sac tumor in postmenopausal females: a case series and a literature review","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.gore.2025.101989_b0080","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1200\/JCO.1994.12.4.701","article-title":"Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group","volume":"12","author":"Williams","year":"1994","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925003145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925003145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:30:44Z","timestamp":1777631444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925003145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":16,"alternative-id":["S2352578925003145"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101989","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatically derived ovarian yolk sac tumor in a postmenopausal woman: A case report of durable remission with personalized chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101989"}}